<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31534118</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>18</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways.</ArticleTitle><Pagination><StartPage>691</StartPage><MedlinePgn>691</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">691</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-019-1910-9</ELocationID><Abstract><AbstractText>Viral myocarditis is potentially fatal and lacking a specific treatment. Exosomes secreted by cardiac progenitor cells (CPCs) have emerged as a promising tool for cardioprotection and repair. In this study, we investigated whether CPCs-derived exosomes (CPCs-Ex) could utilize the mTOR signal pathway to reduce the apoptosis in viral myocarditis. In vitro, exosomes were, respectively, added to H9C2 cells after CVB3 infection to detect the anti-apoptosis effect of CPCs-Ex. Compared with the controls, the apoptosis rate was reduced, accompanied with the depressed expression of viral capsid protein 1 (VP1) and pro-apoptosis factors of Bim/caspase families. Meanwhile, the phosphorylation of Akt, mTOR, and p70S6K were promoted, but that of 4EBP1 was suppressed. In vivo, the results of apoptosis, expression of CVB3 and pro-apoptosis factors, and phosphorylation of Akt/mTOR factors of CVB3-infected cardiomyocytes were consistent with that of vitro. Following that, we use Rapamycin and MK-2206 to inhibit the Akt/mTOR signaling pathway, meanwhile, Rattus 4EBP1, p70S6K, Akt1 and Akt2 were transfected to H9C2 cells to establish the stably transfected cell lines. In the group with Rapamycin or MK-2206 pretreatment, CPCs-Ex also could decrease the apoptosis of H9C2 cells and expression of CVB3 mRNA, followed by decreased expression of apoptosis factors. In Akt2, p70S6K and 4EBP1 overexpression groups, CPCs-Ex promoted CVB3-induced apoptosis, VP1 expression and cleavage of caspase-3. Our results therefore identify CPCs-Ex exerts an anti-apoptosis effect in CVB3-infected cells by abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways as well as the expression of Bcl-2 and caspase families. Viral myocarditis, mainly caused by CVB3 infection, is lacking a specific treatment. Our study identified an anti-apoptosis role of CPCs-Ex in CVB3-infected cells and rats, which shown that CPCs-Ex may be an effective tool to treat viral myocarditis. We believe that with more in-depth research on the functionality of CPCs-Ex, there will be a breakthrough in the treatment of viral myocarditis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China. joyeelee@csu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zuocheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Wenyuan</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-6532-7237</Identifier><AffiliationInfo><Affiliation>Department of Urology, Chinese People's Liberation Army, 89th Hospital, Weifang, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shentang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuoying</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Lang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Sate Key Laboratory of Advanced Welding and Joining, Harbin Institute of Technology (Shenzhen), Shenzhen, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber><NameOfSubstance UI="C546845">mTOR protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="N">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31534118</ArticleId><ArticleId IdType="pmc">PMC6751166</ArticleId><ArticleId IdType="doi">10.1038/s41419-019-1910-9</ArticleId><ArticleId IdType="pii">10.1038/s41419-019-1910-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis-diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 2015;12:670&#x2013;680. doi: 10.1038/nrcardio.2015.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.108</ArticleId><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar S, Liu PP, Cooper LT., Jr. Myocarditis. Lancet. 2012;379:738&#x2013;747. doi: 10.1016/S0140-6736(11)60648-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60648-X</ArticleId><ArticleId IdType="pmc">PMC5814111</ArticleId><ArticleId IdType="pubmed">22185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohnishi S, et al. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J. Mol. Cell Cardiol. 2007;42:88&#x2013;97. doi: 10.1016/j.yjmcc.2006.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2006.10.003</ArticleId><ArticleId IdType="pubmed">17101147</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner L, et al. Transfer of endothelial progenitor cells improves myocardial performance in rats with dilated cardiomyopathy induced following experimental myocarditis. J. Mol. Cell Cardiol. 2005;39:691&#x2013;697. doi: 10.1016/j.yjmcc.2005.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2005.06.015</ArticleId><ArticleId IdType="pubmed">16125196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, et al. The optimal intervention time of bone marrow mesenchymal stem cells in ameliorating cardiac fibrosis induced by viral myocarditis: a randomized controlled trial in mice. Stem Cells Int. 2017;2017:3258035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736900</ArticleId><ArticleId IdType="pubmed">29362568</ArticleId></ArticleIdList></Reference><Reference><Citation>Le T, Chong J. Cardiac progenitor cells for heart repair. Cell Death Discov. 2016;2:16052. doi: 10.1038/cddiscovery.2016.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddiscovery.2016.52</ArticleId><ArticleId IdType="pmc">PMC4979410</ArticleId><ArticleId IdType="pubmed">27551540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chimenti I, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circulation Res. 2010;106:971&#x2013;980. doi: 10.1161/CIRCRESAHA.109.210682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.210682</ArticleId><ArticleId IdType="pmc">PMC4317351</ArticleId><ArticleId IdType="pubmed">20110532</ArticleId></ArticleIdList></Reference><Reference><Citation>Barile L, Milano G, Vassalli G. Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia. Stem Cell Investig. 2017;4:93. doi: 10.21037/sci.2017.11.06.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/sci.2017.11.06</ArticleId><ArticleId IdType="pmc">PMC5723752</ArticleId><ArticleId IdType="pubmed">29270419</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J. Proteom. 2010;73:1907&#x2013;1920. doi: 10.1016/j.jprot.2010.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2010.06.006</ArticleId><ArticleId IdType="pubmed">20601276</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo S, Losordo DW. Exosomes and cardiac repair after myocardial infarction. Circulation Res. 2014;114:333&#x2013;344. doi: 10.1161/CIRCRESAHA.114.300639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.114.300639</ArticleId><ArticleId IdType="pubmed">24436429</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem Biophys. Res. Commun. 2013;431:566&#x2013;571. doi: 10.1016/j.bbrc.2013.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.01.015</ArticleId><ArticleId IdType="pmc">PMC3732190</ArticleId><ArticleId IdType="pubmed">23318173</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, et al. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis. 2016;7:e2277. doi: 10.1038/cddis.2016.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2016.181</ArticleId><ArticleId IdType="pmc">PMC5143405</ArticleId><ArticleId IdType="pubmed">27336721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, et al. A deep proteome analysis identifies the complete secretome as the functional unit of human cardiac progenitor cells. Circulation Res. 2017;120:816&#x2013;834. doi: 10.1161/CIRCRESAHA.116.309782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.309782</ArticleId><ArticleId IdType="pmc">PMC5834230</ArticleId><ArticleId IdType="pubmed">27908912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin J, McIntyre L, Stotland A, Feuer R, Gottlieb RA. Coxsackievirus B escapes the infected cell in ejected mitophagosomes. J. Virol. 2017;91:e01347&#x2013;17. doi: 10.1128/JVI.01347-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-17</ArticleId><ArticleId IdType="pmc">PMC5709598</ArticleId><ArticleId IdType="pubmed">28978702</ArticleId></ArticleIdList></Reference><Reference><Citation>Marier R, et al. Coxsackievirus B5 infection and aseptic meningitis in neonates and children. Am. J. Dis. Child. 1975;129:321&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">1121962</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Cathepsin B aggravates coxsackievirus B3-induced myocarditis through activating the inflammasome and promoting pyroptosis. PLoS Pathog. 2018;14:e1006872. doi: 10.1371/journal.ppat.1006872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006872</ArticleId><ArticleId IdType="pmc">PMC5809100</ArticleId><ArticleId IdType="pubmed">29360865</ArticleId></ArticleIdList></Reference><Reference><Citation>An B, Liu X, Li G, Yuan H. Interleukin-37 ameliorates coxsackievirus B3-induced viral myocarditis by modulating the Th17/regulatory T cell immune response. J. Cardiovasc Pharmacol. 2017;69:305&#x2013;313. doi: 10.1097/FJC.0000000000000476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000476</ArticleId><ArticleId IdType="pubmed">28207428</ArticleId></ArticleIdList></Reference><Reference><Citation>Miteva K, et al. Mesenchymal stromal cells modulate monocytes trafficking in coxsackievirus B3-induced myocarditis. Stem Cells Transl. Med. 2017;6:1249&#x2013;1261. doi: 10.1002/sctm.16-0353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.16-0353</ArticleId><ArticleId IdType="pmc">PMC5442851</ArticleId><ArticleId IdType="pubmed">28186704</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Linthout S, et al. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. Eur. heart J. 2011;32:2168&#x2013;2178. doi: 10.1093/eurheartj/ehq467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq467</ArticleId><ArticleId IdType="pmc">PMC3164101</ArticleId><ArticleId IdType="pubmed">21183501</ArticleId></ArticleIdList></Reference><Reference><Citation>Barile L, et al. Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A. Cardiovasc Res. 2018;114:992&#x2013;1005. doi: 10.1093/cvr/cvy055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvy055</ArticleId><ArticleId IdType="pubmed">29518183</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S. et al. Cardiac progenitor cell-derived exosomes promote H9C2 cell growth via Akt/mTOR activation. Int. J. Mol. Med. 42, 1517&#x2013;1525 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6089767</ArticleId><ArticleId IdType="pubmed">29786755</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik ZA, et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am. J. Physiol. Heart Circ. Physiol. 2013;304:H954&#x2013;965. doi: 10.1152/ajpheart.00835.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00835.2012</ArticleId><ArticleId IdType="pmc">PMC3625894</ArticleId><ArticleId IdType="pubmed">23376832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinescu ME, Gherghiceanu M, Suciu L, Popescu LM. Telocytes in pleura: two- and three-dimensional imaging by transmission electron microscopy. Cell Tissue Res. 2011;343:389&#x2013;397. doi: 10.1007/s00441-010-1095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-010-1095-0</ArticleId><ArticleId IdType="pmc">PMC3032227</ArticleId><ArticleId IdType="pubmed">21174125</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. Overexpression of 4EBP1, p70S6K, Akt1 or Akt2 differentially promotes Coxsackievirus B3-induced apoptosis in HeLa cells. Cell Death Dis. 2013;4:e803&#x2013;809. doi: 10.1038/cddis.2013.331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.331</ArticleId><ArticleId IdType="pmc">PMC3789189</ArticleId><ArticleId IdType="pubmed">24030155</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper LT., Jr. Myocarditis. N. Engl. J. Med. 2009;360:1526&#x2013;1538. doi: 10.1056/NEJMra0800028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0800028</ArticleId><ArticleId IdType="pmc">PMC5814110</ArticleId><ArticleId IdType="pubmed">19357408</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008;103:1204&#x2013;1219. doi: 10.1161/CIRCRESAHA.108.176826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.108.176826</ArticleId><ArticleId IdType="pmc">PMC2667788</ArticleId><ArticleId IdType="pubmed">19028920</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 2014;14:195&#x2013;208. doi: 10.1038/nri3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3622</ArticleId><ArticleId IdType="pmc">PMC4350779</ArticleId><ArticleId IdType="pubmed">24566916</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson SM, Takov K, Yellon DM. Exosomes and cardiovascular protection. Cardiovasc Drugs Ther. 2017;31:77&#x2013;86. doi: 10.1007/s10557-016-6698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-016-6698-6</ArticleId><ArticleId IdType="pmc">PMC5346599</ArticleId><ArticleId IdType="pubmed">27796607</ArticleId></ArticleIdList></Reference><Reference><Citation>Barile L, Moccetti T, Marban E, Vassalli G. Roles of exosomes in cardioprotection. Eur. Heart J. 2017;38:1372&#x2013;1379.</Citation><ArticleIdList><ArticleId IdType="pubmed">27443883</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal U, et al. Experimental, systems, and computational approaches to understanding the microRNA-mediated reparative potential of cardiac progenitor cell-derived exosomes from pediatric patients. Circulation Res. 2017;120:701&#x2013;712. doi: 10.1161/CIRCRESAHA.116.309935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.309935</ArticleId><ArticleId IdType="pmc">PMC5315680</ArticleId><ArticleId IdType="pubmed">27872050</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray WD, et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circulation Res. 2015;116:255&#x2013;U119. doi: 10.1161/CIRCRESAHA.116.304360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.304360</ArticleId><ArticleId IdType="pmc">PMC4338016</ArticleId><ArticleId IdType="pubmed">25344555</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan F, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 2013;10:301&#x2013;312. doi: 10.1016/j.scr.2013.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2013.01.002</ArticleId><ArticleId IdType="pubmed">23399448</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi J, et al. Nox4-dependent ROS production is involved in CVB3-induced myocardial apoptosis. Biochem Biophys. Res. Commun. 2018;503:1641&#x2013;1644. doi: 10.1016/j.bbrc.2018.07.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.07.093</ArticleId><ArticleId IdType="pubmed">30055798</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger A, Baumann S, Krammer PH, Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell Biol. 2001;21:8247&#x2013;8254. doi: 10.1128/MCB.21.24.8247-8254.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.21.24.8247-8254.2001</ArticleId><ArticleId IdType="pmc">PMC99990</ArticleId><ArticleId IdType="pubmed">11713262</ArticleId></ArticleIdList></Reference><Reference><Citation>Banjara S, Mao J, Ryan TM, Caria S, Kvansakul M. Grouper iridovirus GIV66 is a Bcl-2 protein that inhibits apoptosis by exclusively sequestering Bim. J. Biol. Chem. 2018;293:5464&#x2013;5477. doi: 10.1074/jbc.RA117.000591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.000591</ArticleId><ArticleId IdType="pmc">PMC5900755</ArticleId><ArticleId IdType="pubmed">29483196</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis SN, et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science. 2007;315:856&#x2013;859. doi: 10.1126/science.1133289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1133289</ArticleId><ArticleId IdType="pubmed">17289999</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, et al. Exosomes derived from mesenchymal stem cells rescue myocardial ischaemia/reperfusion injury by inducing cardiomyocyte autophagy via AMPK and Akt pathways. Cell Physiol. Biochem. 2017;43:52&#x2013;68. doi: 10.1159/000480317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000480317</ArticleId><ArticleId IdType="pubmed">28848091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al. Overexpression of exosomal cardioprotective miRNAs mitigates hypoxia-induced H9c2 cells apoptosis. Int J. Mol. Sci. 2017;18:E711. doi: 10.3390/ijms18040711.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18040711</ArticleId><ArticleId IdType="pmc">PMC5412297</ArticleId><ArticleId IdType="pubmed">28350318</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Exosomes derived from mesenchymal stromal cells promote axonal growth of cortical neurons. Mol. Neurobiol. 2017;54:2659&#x2013;2673. doi: 10.1007/s12035-016-9851-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9851-0</ArticleId><ArticleId IdType="pmc">PMC5028236</ArticleId><ArticleId IdType="pubmed">26993303</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. Both PI3K-and mTOR-signaling pathways take part in CVB3-induced apoptosis of HeLa cells. DNA Cell Biol. 2013;32:359&#x2013;370. doi: 10.1089/dna.2013.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2013.2003</ArticleId><ArticleId IdType="pubmed">23705975</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HM, et al. Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation. Biochem J. 2016;473:473&#x2013;485. doi: 10.1042/BJ20150419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20150419</ArticleId><ArticleId IdType="pubmed">26621875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, et al. LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway. Mol. Cell Biochem. 2014;385:169&#x2013;177. doi: 10.1007/s11010-013-1825-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-013-1825-1</ArticleId><ArticleId IdType="pubmed">24072614</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers-Broadway KR, et al. Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry. Int J. Mol. Med. 2019;43:47&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6257843</ArticleId><ArticleId IdType="pubmed">30387804</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, et al. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res. 2012;40:761&#x2013;774. doi: 10.1093/nar/gkr730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr730</ArticleId><ArticleId IdType="pmc">PMC3258133</ArticleId><ArticleId IdType="pubmed">21917858</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu JL, et al. The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells. Acta Oncol. 2009;48:1173&#x2013;1180. doi: 10.3109/02841860903032817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02841860903032817</ArticleId><ArticleId IdType="pubmed">19863226</ArticleId></ArticleIdList></Reference><Reference><Citation>Yih LH, Hsu NC, Wu YC, Yen WY, Kuo HH. Inhibition of AKT enhances mitotic cell apoptosis induced by arsenic trioxide. Toxicol. Appl Pharmacol. 2013;267:228&#x2013;237. doi: 10.1016/j.taap.2013.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2013.01.011</ArticleId><ArticleId IdType="pubmed">23352504</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, et al. AKT2 blocks nucleus translocation of apoptosis-inducing factor (AIF) and endonuclease G (EndoG) while promoting caspase activation during cardiac ischemia. Int J. Mol. Sci. 2017;18:E565. doi: 10.3390/ijms18030565.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18030565</ArticleId><ArticleId IdType="pmc">PMC5372581</ArticleId><ArticleId IdType="pubmed">28272306</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Ping, Zhang Yang, Liu Kuikui, Liu Bin, Xu Wenping, Gao Jufang, Ding Lei, Tao Liming. Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway. Cell Proliferation. 2018;52(2):e12543. doi: 10.1111/cpr.12543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.12543</ArticleId><ArticleId IdType="pmc">PMC6496724</ArticleId><ArticleId IdType="pubmed">30515909</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>